Search - tctmd.com

Displaying 881 - 900 of 3285

Sort: Relevancy | Date

Presentation TVT 2022

Potential Solutions: Alternative TMVr Concepts – Annuloplasty and Chordal Replacement Technologies

Presenter: Scott Lim

June 08, 2022

Presentation TVT 2022

Transcatheter Aortic Valve Replacement With the Self-Expanding ACURATE neo2: Hemodynamic Performance and Clinical Outcomes

Presenter: Andrea Scotti

June 08, 2022

Presentation TVT 2022

My Biggest TMVr Frustration: Achieving Consistent and Predictable Results in the “Real World”

Presenter: Paul Sorajja

June 08, 2022

Presentation TVT 2022

Innovation in TMVr: Lessons Learned From the Surgeons

Presenter: Thomas Modine

June 08, 2022

Presentation TVT 2022

First Report of Outcomes of TEER in Patients With Endocardial Leads: Insights From TRILUMINATE and bRIGHT Clinical Trials

Presenter: Georg Nickenig

June 08, 2022

Presentation TVT 2022

Heterotopic Tricuspid Valve Replacement: Considerations for Future Clinical Trials

Presenter: Ori Ben-Yehuda

June 08, 2022

Presentation TVT 2022

Evidence of Structural Valve Deterioration After TAVI: Recent Echo Findings

Presenter: Michael J. Reardon

June 08, 2022

Presentation TVT 2022

Heterotopic Tricuspid Valve Replacement: Future Developments and Novel Applications

Presenter: Brian O'Neill

June 08, 2022

Presentation TVT 2022

Surgical Explants After TAVI Failures: Prohibitive or an Acquired Taste

Presenter: Tsuyoshi Kaneko

June 08, 2022

Presentation TVT 2022

Technical Lessons From TAVI Valve-in-Valve: Contrasting TAV in SAVR and TAV in TAV

Presenter: Janarthanan Sathananthan

June 08, 2022

Presentation TVT 2022

COUNTERPOINT: EU Preferences… Class 1 = ≥ 75 yo

Presenter: Haim Danenberg

June 08, 2022

Presentation TVT 2022

POINT: U.S. Reflections… Class 1 = ≥ 65 yo

Presenter: Philippe Genereux

June 08, 2022

Presentation TVT 2022

From National Registries to Pragmatic Clinical Trials, From Patient-Reported Outcomes to Shared Decision-making: Not One Size Fits All!

Presenter: Sreekanth Vemulapalli

June 08, 2022

Presentation TVT 2022

EFFICACY AND SAFETY OUTCOMES OF CEREBRAL EMBOLIC PROTECTION DEVICES DURING TRANSCATHETER AORTIC VALVE REPLACEMENT: AN UPDATED META-ANALYSIS

Presenter: Arpanjeet Kaur

June 08, 2022

Presentation TVT 2022

Pattern of Hospital-Level Use of Cerebral Embolic Protection for Transcatheter Aortic Valve Replacement and Association with Outcomes

Presenter: AAMER UBAID

June 08, 2022

Presentation TVT 2022

The TRICUS Study EURO: Clinical Results (TricValve)

Presenter: Rodrigo Estevez-Loureiro

June 08, 2022

Presentation TVT 2022

Transcatheter versus surgical aortic valve replacement for severe aortic stenosis: a meta-analysis of randomized clinical trials

Presenter: Yousif Ahmad

June 08, 2022

Presentation TVT 2022

Heterotopic Tricuspid Valve Replacement: Patient Selection and Anatomical Requirements

Presenter: Fabio Brito Jr.

June 08, 2022

Presentation TVT 2022

Keynote Lecture: Unlocking the Mysteries of Tricuspid Valve Disease: Controversies and Technologies1

Presenter: Azeem Latib

June 08, 2022

Presentation TVT 2022

Heterotopic Tricuspid Valve Replacement: From Bench to Bedside

Presenter: Samir Kapadia

June 08, 2022

Advertisement

Potential Solutions: Alternative TMVr Concepts – Annuloplasty and Chordal Replacement Technologies

Transcatheter Aortic Valve Replacement With the Self-Expanding ACURATE neo2: Hemodynamic Performance and Clinical Outcomes

My Biggest TMVr Frustration: Achieving Consistent and Predictable Results in the “Real World”

Innovation in TMVr: Lessons Learned From the Surgeons

First Report of Outcomes of TEER in Patients With Endocardial Leads: Insights From TRILUMINATE and bRIGHT Clinical Trials

Heterotopic Tricuspid Valve Replacement: Considerations for Future Clinical Trials

Evidence of Structural Valve Deterioration After TAVI: Recent Echo Findings

Heterotopic Tricuspid Valve Replacement: Future Developments and Novel Applications

Surgical Explants After TAVI Failures: Prohibitive or an Acquired Taste

Technical Lessons From TAVI Valve-in-Valve: Contrasting TAV in SAVR and TAV in TAV

COUNTERPOINT: EU Preferences… Class 1 = ≥ 75 yo

POINT: U.S. Reflections… Class 1 = ≥ 65 yo

From National Registries to Pragmatic Clinical Trials, From Patient-Reported Outcomes to Shared Decision-making: Not One Size Fits All!

EFFICACY AND SAFETY OUTCOMES OF CEREBRAL EMBOLIC PROTECTION DEVICES DURING TRANSCATHETER AORTIC VALVE REPLACEMENT: AN UPDATED META-ANALYSIS

Pattern of Hospital-Level Use of Cerebral Embolic Protection for Transcatheter Aortic Valve Replacement and Association with Outcomes

The TRICUS Study EURO: Clinical Results (TricValve)

Transcatheter versus surgical aortic valve replacement for severe aortic stenosis: a meta-analysis of randomized clinical trials

Heterotopic Tricuspid Valve Replacement: Patient Selection and Anatomical Requirements

Keynote Lecture: Unlocking the Mysteries of Tricuspid Valve Disease: Controversies and Technologies1

Heterotopic Tricuspid Valve Replacement: From Bench to Bedside

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content